KACI MEDLEY: Open Payments
NPI 1821624339 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,971 in 121 payments from 23 companies in 2025. Trend: 2023 $1,921 · 2024 $1,961 · 2025 $2,971
Food & beverage: $2,854Education: $117
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $597 |
| GlaxoSmithKline, LLC. | 23 | $382 |
| Insmed, Inc. | 12 | $315 |
| Regeneron Healthcare Solutions, Inc. | 9 | $237 |
| Verona Pharma, Inc. | 7 | $190 |
| Viatris Specialty LLC | 8 | $141 |
| INTUITIVE SURGICAL, INC. | 1 | $120 |
| GENZYME CORPORATION | 6 | $115 |
| Amgen Inc. | 6 | $111 |
| Actelion Pharmaceuticals US, Inc. | 1 | $104 |
Products named: DUPIXENT, Arikayce, AIRSUPRA, TRELEGY ELLIPTA, Ohtuvayre, TEZSPIRE, NUCALA, BREZTRI.
Industry payments across KY — which companies pay providers there.
